Percutaneous Mitral Valve Repair in Mitral Regurgitation Reduces Cell-Free Hemoglobin and Improves Endothelial Function.
BACKGROUND AND OBJECTIVE:Endothelial dysfunction is predictive for cardiovascular events and may be caused by decreased bioavailability of nitric oxide (NO). NO is scavenged by cell-free hemoglobin with reduction of bioavailable NO up to 70% subsequently deteriorating vascular function. While patien...
Main Authors: | Christos Rammos, Tobias Zeus, Jan Balzer, Laura Kubatz, Ulrike B Hendgen-Cotta, Verena Veulemans, Katharina Hellhammer, Matthias Totzeck, Peter Luedike, Malte Kelm, Tienush Rassaf |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4795750?pdf=render |
Similar Items
-
Safety and efficacy of percutaneous mitral valve repair using the MitraClip® system in patients with diabetes mellitus.
by: Katharina Hellhammer, et al.
Published: (2014-01-01) -
High body mass index is a risk factor for difficult deep sedation in percutaneous mitral valve repair.
by: Katharina Hellhammer, et al.
Published: (2018-01-01) -
Filtration of Macrophage Migration Inhibitory Factor (MIF) in Patients with End Stage Renal Disease Undergoing Hemodialysis.
by: Peter Luedike, et al.
Published: (2015-01-01) -
Percutaneous mitral valve repair: A new treatment for mitral regurgitation
by: Claire Kelley, et al.
Published: (2016-05-01) -
Contemporary Echocardiographic Evaluation of Mitral Regurgitation and Guidance for Percutaneous Mitral Valve Repair
by: Davide Marchetti, et al.
Published: (2023-11-01)